Tom Dubensky

Tom Dubensky is a seasoned biotech executive and entrepreneur with over 35 years of experience in the biotechnology industry.1 He currently serves as the President & CEO of ImmuneSensor Therapeutics, a privately held, clinical-stage company.2

Career Highlights

Dubensky's career spans various roles in the biotech sector, including:

• Research Scientist to CEO: He has worked in positions ranging from Research Scientist to CEO in both venture-backed startups and public biotechnology companies.1
• Drug Development: Dubensky has been involved in developing first-in-class drugs from conception through early-stage clinical development.1
• Strategic Leadership: He has extensive experience in establishing strategy, leading discovery research, and overseeing IND-enabling activities.1

Expertise

Tom Dubensky's areas of expertise include:

• Scientific Background: He possesses a deep scientific knowledge, particularly in oncology and infectious diseases.1
• Translational Research: Dubensky has experience in translating research findings into early clinical phase evaluation of novel therapies.1
• Partnership Building: He has a proven record of establishing productive academic and corporate partnerships, leading to the development of new platforms and products.1

Recent Developments

In August 2023, Tom Dubensky announced that he had joined ImmuneSensor Therapeutics as its President & CEO.2 The company is focused on clinical-stage development, likely in the field of immunotherapy given its name.

Tom Dubensky's extensive experience in biotechnology, combined with his leadership roles in various companies, positions him as a prominent figure in the biotech industry, particularly in the development of innovative therapeutics.